Significant financial differences of chemical and surgical androgen deprivation in a contemporary cohort.

Paul, Charles J; Garje, Rohan; Kreder, Karl J; Mott, Sarah L; Gellhaus, Paul T

Paul, Charles J; Garje, Rohan; Kreder, Karl J; Mott, Sarah L; Gellhaus, Paul T.

Afiliação

Paul CJ; Department of Urology, University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
Garje R; Holden Comprehensive Cancer Center, University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
Kreder KJ; Department of Urology, University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
Mott SL; Holden Comprehensive Cancer Center, University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
Gellhaus PT; Department of Urology, University of Iowa Hospitals & Clinics, Iowa City, IA, USA.

Transl Androl Urol ; 11(9): 1252-1261, 2022 Sep.

Article em En | MEDLINE | ID: mdl-36217391

Palavras-chave

Costs and cost analysis; castration; gonadotropin-releasing hormone (GnRH); orchiectomy; prostatic neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Transl Androl Urol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google